使用癌症幸存者的叙述来增加父母的人类乳头瘤病毒疫苗接种意图
Mary A Gerend1, Christina T Myers1, Amy McQueen2
1Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University.
概括
关于人类乳头瘤病毒 (HPV) 疫苗接种的叙事信息,特别是那些涉及癌症幸存者的叙事信息,显示出增加家长接种疫苗的意图的希望. 这些情感上的吸引力可能会比单纯的事实信息更有效地提高疫苗接种率.
科学领域:
- 公共卫生 公共卫生
- 卫生沟通健康沟通
- 疫苗学 疫苗学 疫苗学
背景情况:
- 人类乳头瘤病毒 (HPV) 疫苗接种对于预防HPV相关癌症至关重要.
- 需要有效的沟通策略来解决家长的犹和增加HPV疫苗接种率.
- 叙事信息可能比传统的信息内容提供更有吸引力的方法.
研究的目的:
- 为了比较关于HPV疫苗接种的三个叙述性传播信息的初步有效性和可接受性,与基于事实的信息控制信息进行比较.
- 评估不同叙事主题 (角色模范,癌症前期幸存者,癌症幸存者) 对父母HPV疫苗接种意图的影响.
主要方法:
- 一项全国性的在线实验涉及948名9-17岁未接种疫苗的孩子的父母.
- 参与者被随机分配观看四个视频中的一个:信息控制,榜样叙述,癌症前期幸存者叙述或癌症幸存者叙述.
- 接种HPV疫苗的意图,信息接受和拒绝是初级和二级结果变量,使用ANOVA和回归分析.
主要成果:
- 所有的信息都得到了很好的接受,拒绝率很低.
- 与对照组相比,接触过癌症幸存者的叙事信息的家长报告说,与对照组相比,他们的孩子接种疫苗的意图明显更高.
- 癌症幸存者叙述的积极影响是由增加的情感参与的介导.
结论:
- 癌症幸存者的叙述代表了增加HPV疫苗接种的潜在有效干预策略.
- 情感参与似乎是这些叙事影响父母决策的关键机制.
- 对HPV疫苗接种基于叙事的干预措施的进一步研究是有必要的.
相关概念视频
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


